News & Updates

Breastfeeding reduces risk of infant RTIs

Infants who have been fully breastfed for 6 months up to at least 1 year appear to have a lower risk of subsequent respiratory tract infections (RTIs) and hospitalization from RTIs, a study has shown.

Diet plus physical activity mitigates weight loss-related decline in BMD in older women

In older women with metabolic syndrome, a lifestyle intervention based on energy-reduced Mediterranean diet plus physical activity lifestyle appears to mitigate the effects of weight loss on bone mineral density (BMD), according to the results of the 3-year, parallel-group PREDIMED-Plus trial.

Apixaban (Eliquis): Superior anticoagulation efficacy with minimized bleeding risks

Primary stroke mechanism identification helps predict recurrent stroke risk

In medically treated symptomatic intracranial atherosclerotic stenosis (sICAS) patients, considering artery-to-artery embolism (AAE) rather than hypoperfusion as the stroke mechanism for cortical borderzone (CBZ) infarcts could better predict early recurrent stroke in the same territory (SIT), a study by the Chinese University of Hong Kong (CUHK) has found.

Palliative care needed in patients with progressive neurologic diseases

Early recognition and management of emerging palliative care (PC) needs, particularly psychospiritual distress, is crucial for enhancing health-related quality of life (HRQoL) for patients with peripheral neurologic diseases (PNDs), a study by the University of Hong Kong (HKU) has found.  

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-April-2025

New drug applications approved by US FDA as of 1-15 April 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Higher muscle strength associated with lower T2D risk

Higher muscle strength is associated with lower relative risk of developing type 2 diabetes (T2D), irrespective of genetic susceptibility to T2D, while such association is weaker in the high genetic risk group, researchers from the University of Hong Kong (HKU) have found.

Meta-analysis favours glucose-lowering with GLP-1RA for dementia risk

In the management of diabetes, users of glucagon-like peptide-1 receptor agonists (GLP-1RAs) appear to have a lower risk of all-cause dementia compared with users of other glucose-lowering medications, according to a systematic review and meta-analysis.